A user-friendly filtration tool using a chitosan nanofiber/silver nanocomposite membrane for one-step enrichment and surface-enhanced Raman spectroscopy (SERS) detection of acrylamide in drinking water. Designed to deliver sensitive (< 0.5 ppb), rapid (< 5 min), and low-cost (< $5 per test) results in real time, addressing a key food and water safety challenge.
This project develops a chitosan nanofiber/silver nanocomposite membrane integrated into a simple filter device for detecting acrylamide in drinking water. Acrylamide is a probable carcinogen that can form during high-temperature cooking and processing of certain foods, making reliable detection in water supplies an important public health priority. The solution combines surface-enhanced Raman spectroscopy (SERS), a technique that amplifies the molecular signals of target analytes on nanostructured metal surfaces, with a chitosan-based filtration membrane that captures and concentrates acrylamide in a single step. The result is a portable, easy-to-use tool that delivers laboratory-grade sensitivity without the need for complex sample preparation or specialized operators.
Core technology:
Performance targets:
Key advantages:
The project is at an early-to-mid development stage with a six-month research plan. Phase one involves fabricating the chitosan membrane via electrospinning and preparing the PDA@AgNPs composites. Phase two focuses on immobilizing the silver nanocomposites onto the membrane and optimizing SERS performance for sensitivity and accuracy. Phase three integrates the optimized membrane into a prototype filter device to create the user-friendly CAN Tool. The final phase applies the tool to real drinking water samples using a portable Raman instrument and conducts validation studies to confirm sensitivity, accuracy, and field readiness. The research team brings complementary expertise in SERS substrate development and acrylamide validation using chromatography, supporting a credible path toward a deployable detection platform.
UBC is a comprehensive public research university with major campuses in Vancouver and the Okanagan, among Canada’s largest and most internationally connected. Industry engages through a co-op talent pipeline and collaborative research spaces that include co-located clinical settings and on‑campus testbeds. A dedicated technology transfer office brokers partnerships, manages IP and licensing, and is complemented by an active venture accelerator and incubator network. Research is supported by competitive funding from Canada’s Tri‑Council agencies (NSERC, CIHR, SSHRC) and infrastructure investments from the Canada Foundation for Innovation, alongside provincial and industry sponsorship.